Status | Study |
Active, not recruiting |
Study Name: Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma Condition: Childhood Alveolar Soft-part Sarcoma Childhood Angiosarcoma Date: 2012-06-06 Interventions: Biological: cixutumumab Given |
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Date: 2012-02-06 Interventions: Drug: Gemcitabine Hydrochloride |
Recruiting |
Study Name: Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma Condition: Adult Angiosarcoma Recurrent Adult Soft Tissue Sarcoma Date: 2011-10-27 Interventions: Drug: pazopanib hydrochloride |
Active, not recruiting |
Study Name: Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas Condition: Angiosarcoma Date: 2011-02-23 Interventions: Drug: Paclitaxel Day 1, 8 and |
Completed |
Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Date: 2010-06-29 Interventions: Drug: Gamma-Secretase Inhibitor RO4929097 |
Active, not recruiting |
Study Name: A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas Condition: Soft Tissue Sarcoma Date: 2010-06-08 Interventions: Drug: Axitinib Patients will take axitinib tablets 5 mg by mouth twice daily continuously. There may be |
Active, not recruiting |
Study Name: Paclitaxel + Bevacizumab (Avastin®) for the Treatment of Metastatic or Unresectable Angiosarcoma Condition: Angiosarcomas Soft Tissue Sarcoma Date: 2010-01-21 Interventions: Drug: Paclitaxel in combination with Bevacizumab 15 mg/kg, IV |
Completed |
Study Name: Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes Condition: Sarcoma Leiomyosarcoma Malignant Fibrous Date: 2009-04-23 Interventions: Drug: gemcitabine Drug: docetaxel |
Recruiting |
Study Name: Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery Condition: Sarcoma Date: 2009-04-02 Interventions: Drug: sorafenib tosylate |
Completed |
Study Name: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Condition: Adult Angiosarcoma Adult Desmoplastic Small Round Cell Tumor Date: 2008-07-19 Interventions: Biological: Cixutumumab Given |